Using the link below (USGS Earthquake Hazards Program), search in Washington state for earthquake history, maps, and data. Provide a summary, with maps of Washington state in the Olympia WA area, and discuss any historical events that may have occurred or seismic activity that is current. You may be surprised to see that you actually live near a fault line or in an area with historical earthquake events.
https://www.usgs.gov/natural-hazards/earthquake-hazards/information-region (Links to an external site.)
Unit 4 Discussion: How can GPS data help in the Prediction of Earthquakes: Part II
After watching the following video:
Describe the possible uses of GPS/GIS in predicting plate movement and how this may allow for appropriate safety actions.
mate (20 mM in 1% formic acid) (5:95 v/v) and (B) acetonitrile:ammonium formate (10 mM in 1% formic acid) (80:20 v/v) and were run according to previously described gradient program(Blessborn et al. 2010). The compounds were analyzed on a Tosoh ” 5 ”m C18 (150 mm ” 2 mm) column protected by a precolumn security guard C8 (8mm x2 mm) (Tosoh Bioscience, PA). The UV detector was monitored at 280nm. Data acquisition and quantification were performed using HystarTM and Data AnalysisTM (Bruker, Bremen, Germany). Estimation of dose intake time for SDX To estimate the probable timing of drug intake, we compared the whole blood concentrations of SDX at baseline (C0) and on Day 7 (C7) after a complete treatment with AS+SP for the same patients. Assuming a terminal elimination half-life (t”) of 7.2 days for SDX, an inter-individual variability of 30% and a similar dosage on pre-study exposure and during the study, a back-calculation was done to estimate the intake time of the drug before baseline sampling: Intake time =ln(C7/C0).t1/2/ln(2)+7[days] The variability on t” was used to estimate a 90% confidence interval around this intake time, considering plausible inter-individual variations in elimination rate (White et al. 1999). Similar calculation was not attempted for PYR because of its short half-life period (Hodel et al. 2009). Isolation of genomic DNA Parasites genomic DNA was extracted from clinical samples by using QIAamp DNA min kit (Qiagen, valencia, CA) according to the manufacturer’s protocol with slight modification. Pfdhfr and pfdhps gene products were amplified using earlier reported methods (Duarai singh et al., 1998) and then digested using restriction enzymes for analysing point mutations in Pfdhfr (codon 51, 59, 108 and 164), Pfdhps gene(436, 437, 540, 581 and 613) and pfcrt mutation analysis was done according to Vathsala et al 2004. Applied Biosystem thermocycler was used for all PCR amplification reactions. Digested PCR product (5-8 microlitre) was analysed on 1.5 % agarose gel containing ethidium bromide>GET ANSWER